FDA Clearance Tracker · P160055-S054
RxSight Light Adjustable Lens; Light Delivery Device
Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2026
Approved
Time to decision
269 days
Received Sep 30, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160055-S054
- Device name
- RxSight Light Adjustable Lens; Light Delivery Device
- Applicant
- Rxsight, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Sep 30, 2025
- Decided
- Jun 26, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P160055
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
for a reconfiguration of the labeling approved for the Light Adjustable Lens and Light Delivery Device, and to update the content of the labeling approved for the Light Adjustable Lens and Light Delivery Device
Source documents
Other decisions for Rxsight, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261174 · Decided Jun 10, 2026 · 62 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.